Nasus Pharma Ltd

Predicción y previsión de precio de Nasus Pharma Ltd (NSRX)

$3.825

-0.243 (-6.34%)Al cierre

Predicciones de precio

1-Day Price Prediction
-0.10%
1-Week Prediction
-6.62%
1-Month Prediction
2026 Prediction
2030 Prediction

Ábrelo en la app para desbloquear previsiones a más largo plazo.

Loading chart…

Predicción y previsión de NSRX por análisis de gráficos similares

Alphio's NSRX stock price prediction model matches the current Nasus Pharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.82 (-0.10%). The 1-week path is $3.57 (-6.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

¿Debería comprar acciones de Nasus Pharma Ltd?

Nasus Pharma Ltd is a good buy right now due to its recent price increase of 35.31% over the last 20 days and a current RSI of 78.7, indicating strong momentum. The company has successfully raised $15 million to fund clinical trials, which enhances its financial stability. However, the main risk is the high current liabilities of $4.95 million compared to current assets of only $291,000 in Q2 2025, indicating potential liquidity issues in the short term.

NSRX cerró en $3.83 el Tuesday, tras bajar -6.34%

Nasus Pharma Ltd (NSRX) last closed at $3.825, losing -6.34%. These facts feed the 1-day and 1-week NSRX price prediction above.

Factores de la previsión

Los factores de la previsión de Nasus Pharma Ltd (NSRX) combinan patrones gráficos similares, estacionalidad y medias móviles.

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

Patrones gráficos similares

Acciones cuya trayectoria reciente más se parece a la de NSRX, ordenadas por similitud.

Análisis de estacionalidad de NSRX

Historically the probability of a positive September return for NSRX is 63.64%. September offers the highest probability of a positive month at 63.64%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis